Angela Hee, DMD, MPH

Head of Clinical Operations of Hengrui Therapeutics​​​

Dr. Angela Hee joins HTI from Mitsubishi Tanabe Pharma Development America, Inc. (MTDA) where she was Senior Director and Head of Clinical and Technical Operations. Her role at MTDA focused on building a high functioning clinical operations group especially in CRO management and upgrading technical systems, developing functional procedures and processes that support evolving organizational changes, and contributing to due diligence reviews on compounds for potential in-licensing and development or out-licensing. Prior to MTDA, Dr. Hee was at Otsuka as the medical monitor responsible for several Phase 3 psychiatric indication studies that led to a recent NDA approval. Her career in the pharmaceutical industry started at the Institute of Molecular Biology where she was the trial manager on human growth factor studies in dental and diabetic indications. Dr. Hee has held increasing global Phase 1-4 clinical research leadership positions at AstraZeneca, Johnson & Johnson Consumer and Personal Products Worldwide, Inc., and OraPharma, including strategic development interactions with 5 different FDA divisions and approvals of 2 NDAs, over 20 sNDAs, and 2 device 510Ks.
​
Dr. Hee received her DMD degree from the University of the Philippines College of Dentistry in the Philippines, and her MPH degree from Harvard University Chan School of Public Health in Boston, MA.